T1D Diagnosis? Gut Bacteria May Hold the Clue
Over the past 50 years, type 1 diabetes (T1D) has increased significantly in many developed countries around the world. There…
SGLT Inhibition: It’s Not Just for Type 2 Anymore
Can a drug long-used for type 2 diabetes, also help those with T1D? The European body that approves medicines for…
We’re the Advancing Progress Type
Breakthrough T1D Fiscal Year 2018 Annual Report As you’ll see in the pages of our fiscal year 2018 annual report,…
GK Activator Clinical Trial Results
A protein, called glucokinase (or GK), acts as a key regulator of sugar levels in the body, and its expression…
Breakthrough T1D Leads Push to Develop a Vaccine for Viral Infections that Could Trigger T1D
Scientists worldwide are attempting to determine why some people predisposed to type 1 diabetes (T1D) eventually end up developing the…
An Important Step in the FDA Review of Sotagliflozin (Zynquista™) for T1D
You’ll hear it again and again: For some people with type 1 diabetes (T1D), SGLT inhibitor therapy* means taking less…
